FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

James Willson

Research Profile

Disorders

Anatomy

Living Beings

Physiology

Chemicals & Drugs

Procedures

Concepts & Ideas

Molecular Sequence Data

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Jihye Yun; Carlo Rago; Ian Cheong; Ray Pagliarini; Philipp Angenendt; Harith Rajagopalan; Kerstin Schmidt; James Willson; Sanford Markowitz; Shibin Zhou; Luis Alberto Diaz; Victor E Velculescu; Christoph Lengauer; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos
Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells.
Kishore Guda; Helen Moinova; Jian He; Oliver Jamison; Lakshmeswari Ravi; Leanna Natale; James Lutterbaugh; Earl Lawrence; Susan Lewis; James Willson; John B Lowe; Georgia L Wiesner; Giovanni Parmigiani; Jill S Barnholtz-Sloan; Dawn W Dawson; Victor E Velculescu; Kenneth W Kinzler; Nickolas Papadopoulos; Bert Vogelstein; Joseph Willis; Thomas A Gerken; Sanford D Markowitz
Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers.
Chunguang Guo; Jerome Sah; Lydia Beard; James Willson; Sanford D Markowitz; Kishore Guda
The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of James Willson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2009: Jihye Yun; Carlo Rago; Ian Cheong; Ray Pagliarini; Philipp Angenendt; Harith Rajagopalan; Kerstin Schmidt; James Willson; Sanford Markowitz; Shibin Zhou; Luis Alberto Diaz; Victor E Velculescu; Christoph Lengauer; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos
Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells.
Science (New York, N.Y.) 2009;325(5947):1555-9.
2009: Kishore Guda; Helen Moinova; Jian He; Oliver Jamison; Lakshmeswari Ravi; Leanna Natale; James Lutterbaugh; Earl Lawrence; Susan Lewis; James Willson; John B Lowe; Georgia L Wiesner; Giovanni Parmigiani; Jill S Barnholtz-Sloan; Dawn W Dawson; Victor E Velculescu; Kenneth W Kinzler; Nickolas Papadopoulos; Bert Vogelstein; Joseph Willis; Thomas A Gerken; Sanford D Markowitz
Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(31):12921-5.
2008: Chunguang Guo; Jerome Sah; Lydia Beard; James Willson; Sanford D Markowitz; Kishore Guda
The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers.
Genes, chromosomes & cancer 2008;47(11):939-46.
2008: Rebecca J Leary; Jimmy C Lin; Jordan Cummins; Simina Boca; Laura D Wood; DONALD PARSONS; Siân Jones; Tobias Sjöblom; Ben Ho Park; Ramon Parsons; Joseph Willis; Dawn Dawson; James Willson; Tatiana Nikolskaya; Yuri Nikolsky; Levy Kopelovich; Nickolas Papadopoulos; Len A Pennacchio; Tian-Li Wang; Sanford D Markowitz; Giovanni Parmigiani; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(42):16224-9.
2008: Timothy J Kinsella; Yuji Seo; Joseph Willis; Thomas A Stellato; Christopher T Siegel; Deborah Harpp; James Willson; Joseph Gibbons; Juan R Sanabria; Jeffrey M Hardacre; James P Schulak
The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer.
American journal of clinical oncology 2008;31(5):446-53.
2008: Chunguang Guo; Xiaodong Zhang; Stephen P Fink; Petra Platzer; Keith Wilson; James Willson; Zhenghe Wang; Sanford D Markowitz
Ugene, a newly identified protein that is commonly overexpressed in cancer and binds uracil DNA glycosylase.
Cancer research 2008;68(15):6118-26.
2008: William M Grady; R K Parkin; P S Mitchell; J H Lee; Y-H Kim; K D Tsuchiya; M K Washington; C Paraskeva; James Willson; A M Kaz; E M Kroh; A Allen; B R Fritz; Sanford D Markowitz; M Tewari
Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer.
Oncogene 2008;27(27):3880-8.
2008: Swati Biswas; Patricia Trobridge; Judith Romero-Gallo; Dean Billheimer; Lois L Myeroff; James Willson; Sanford D Markowitz; William M Grady
Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells.
Genes, chromosomes & cancer 2008;47(2):95-106.
2007: Laura D Wood; DONALD PARSONS; Siân Jones; Jimmy Lin; Tobias Sjöblom; Rebecca J Leary; Dong Shen; Simina M Boca; Thomas Barber; Janine Ptak; Natalie Silliman; Stephen Szabo; Zoltan Dezso; Vadim Ustyanksky; Tatiana Nikolskaya; Yuri Nikolsky; Rachel Karchin; Paul A Wilson; Joshua S Kaminker; Zemin Zhang; Randal L. Croshaw; Joseph Willis; Dawn Dawson; Michail Shipitsin; James Willson; Saraswati Sukumar; Kornelia Polyak; Ben Ho Park; Charit L Pethiyagoda; P V Krishna Pant; Dennis G Ballinger; Andrew B Sparks; James Hartigan; Douglas R Smith; Erick Suh; Nickolas Papadopoulos; Phillip Buckhaults; Sanford D Markowitz; Giovanni Parmigiani; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein
The genomic landscapes of human breast and colorectal cancers.
Science (New York, N.Y.) 2007;318(5853):1108-13.
2007: Jing Wang; Karen Kuropatwinski; Jennie Hauser; Michael R Rossi; Yunfei Zhou; Alexis Conway; Julie L C Kan; Neil W Gibson; James Willson; John Kenneth Cowell; Michael G Brattain
Colon carcinoma cells harboring PIK3CA mutations display resistance to growth factor deprivation induced apoptosis.
Molecular cancer therapeutics 2007;6(3):1143-50.
2007: Ashwani Rajput; Alan P Koterba; Jeffrey I Kreisberg; Jason M Foster; James Willson; Michael G Brattain
A novel mechanism of resistance to epidermal growth factor receptor antagonism in vivo.
Cancer research 2007;67(2):665-73.
2006: Tobias Sjöblom; Siân Jones; Laura D Wood; DONALD PARSONS; Jimmy Lin; Thomas D Barber; Diana Mandelker; Rebecca J Leary; Janine Ptak; Natalie Silliman; Stephen Szabo; Phillip Buckhaults; Christopher Farrell; Paul Meeh; Sanford D Markowitz; Joseph Willis; Dawn Dawson; James Willson; Adi F Gazdar; James Hartigan; Leo Wu; Changsheng Liu; Giovanni Parmigiani; Ben Ho Park; Kurtis E Bachman; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu
The consensus coding sequences of human breast and colorectal cancers.
Science (New York, N.Y.) 2006;314(5797):268-74.
2006: Yunfei Zhou; Song Li; Yi P Hu; Jing Wang; Jennie Hauser; Alexis N Conway; Michelle A Vinci; Lisa E Humphrey; Elizabeth Zborowska; James Willson; Michael G Brattain
Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.
Cancer research 2006;66(1):404-11.
2005: DONALD PARSONS; Tian-Li Wang; Yardena Samuels; Alberto Bardelli; Jordan M Cummins; Laura DeLong; Natalie Silliman; Janine Ptak; Stephen Szabo; James Willson; Sanford Markowitz; Kenneth W Kinzler; Bert Vogelstein; Christoph Lengauer; Victor E Velculescu
Colorectal cancer: mutations in a signalling pathway.
Nature 2005;436(7052):792.
2005: Wei-Dong Chen; Z James Han; Joel Skoletsky; Jeff Olson; Jerome Sah; Lois Myeroff; Petra Platzer; Shi-Long Lu; Dawn Dawson; Joseph Willis; Theresa P Pretlow; James Lutterbaugh; Lakshmi Kasturi; James Willson; Jonnagadda Sunil Rao; Anthony P Shuber; Sanford D Markowitz
Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.
Journal of the National Cancer Institute 2005;97(15):1124-32.
2005: Yi Peter Hu; Srinivas Venkateswarlu; Natalia Sergina; Gillian M Howell; Patricia St Clair; Lisa E Humphrey; Wenhui Li; Jennie Hauser; Elizabeth Zborowska; James Willson; Michael G Brattain
Reorganization of ErbB family and cell survival signaling after Knock-down of ErbB2 in colon cancer cells.
The Journal of biological chemistry 2005;280(29):27383-92.
2005: Baozhong Xin; Petra Platzer; Stephen P Fink; Lisa Reese; Arman Nosrati; James Willson; Keith Wilson; Sanford Markowitz
Colon cancer secreted protein-2 (CCSP-2), a novel candidate serological marker of colon neoplasia.
Oncogene 2005;24(4):724-31.
2004: Min Yan; Ronald M Rerko; Petra Platzer; Dawn Dawson; Joseph Willis; Min Tong; Earl Lawrence; James Lutterbaugh; Shi-Long Lu; James Willson; Guangbin Luo; Jack O Hensold; Hsin-Hsiung Tai; Keith Wilson; Sanford D Markowitz
15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(50):17468-73.
2004: Zhenghe Wang; Dong Shen; DONALD PARSONS; Alberto Bardelli; Jason A Sager; Stephen Szabo; Janine Ptak; Natalie Silliman; Brock A Peters; Michiel S van der Heijden; Giovanni Parmigiani; Hai Yan; Tian-Li Wang; Gregory J Riggins; Steven M Powell; James Willson; Sanford Markowitz; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Mutational analysis of the tyrosine phosphatome in colorectal cancers.
Science (New York, N.Y.) 2004;304(5674):1164-6.
2004: Zhenghe Wang; Jordan M Cummins; Dong Shen; Daniel P Cahill; Prasad V Jallepalli; Tian-Li Wang; DONALD PARSONS; Giovanni Traverso; Mark Awad; Natalie Silliman; Janine Ptak; Stephen Szabo; James Willson; Sanford D Markowitz; Michael L Goldberg; Roger Karess; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu; Christoph Lengauer
Three classes of genes mutated in colorectal cancers with chromosomal instability.
Cancer research 2004;64(9):2998-3001.
2004: Yardena Samuels; Zhenghe Wang; Alberto Bardelli; Natalie Silliman; Janine Ptak; Stephen Szabo; Hai Yan; Adi F Gazdar; Steven M Powell; Gregory J Riggins; James Willson; Sanford Markowitz; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
High frequency of mutations of the PIK3CA gene in human cancers.
Science (New York, N.Y.) 2004;304(5670):554.
2003: Jennifer D Black; Michael G Brattain; Smitha A Krishnamurthi; Dawn M Dawson; James Willson
ErbB family targeting.
Current opinion in investigational drugs (London, England : 2000) 2003;4(12):1451-4.
2003: Kou-Yi Tserng; Stephen T Ingalls; Erik M Boczko; Timothy P Spiro; Xiaolin Li; Susan Majka; Stanton L Gerson; James Willson; Charles L Hoppel
Pharmacokinetics of O6-benzylguanine (NSC637037) and its metabolite, 8-oxo-O6-benzylguanine.
Journal of clinical pharmacology 2003;43(8):881-93.
2003: Rana A Awwad; Natalia Sergina; Haisu Yang; Barry Ziober; James Willson; Elizabeth Zborowska; Lisa E Humphrey; Robert Fan; Tien C Ko; Michael G Brattain; Gillian M Howell
The role of transforming growth factor alpha in determining growth factor independence.
Cancer research 2003;63(15):4731-8.
2003: Hui Li; Lois Myeroff; Dominic J Smiraglia; Michael F Romero; Theresa P Pretlow; Lakshmi Kasturi; James Lutterbaugh; Ronald M Rerko; Graham Casey; Jean-Pierre J Issa; Joseph Willis; James Willson; Christoph Plass; Sanford D Markowitz
SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(14):8412-7.
2003: Alberto Bardelli; DONALD PARSONS; Natalie Silliman; Janine Ptak; Stephen Szabo; Saurabh Saha; Sanford Markowitz; James Willson; Giovanni Parmigiani; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Mutational analysis of the tyrosine kinome in colorectal cancers.
Science (New York, N.Y.) 2003;300(5621):949.
2003: Elaine B Brunschwig; Keith Wilson; David Mack; Dawn Dawson; Earl Lawrence; James Willson; Shi-Long Lu; Arman Nosrati; Ronald M Rerko; Sandra Swinler; Lydia Beard; James Lutterbaugh; Joseph Willis; Petra Platzer; Sanford Markowitz
PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.
Cancer research 2003;63(7):1568-75.
2003: Stephen P Fink; Debra Mikkola; James Willson; Sanford Markowitz
TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Oncogene 2003;22(9):1317-23.
2003: Paula M Hempen; Lin Zhang; Ravi K Bansal; Christine A Iacobuzio-Donahue; KATHLEEN MURPHY; Anirban Maitra; Bert Vogelstein; Robert H Whitehead; Sanford D Markowitz; James Willson; Charles J Yeo; Ralph Hruban; Scott E Kern
Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers.
Cancer research 2003;63(5):994-9.
2002: June L Traicoff; James Willson; Sanford D Markowitz
Early loss of deleted in colorectal carcinoma gene transcript detected in a group of benign colon adenomas.
Journal of biomedical science 2002;9(6 Pt 2):716-20.
2002: Helen R Moinova; Wei-Dong Chen; Lanlan Shen; Dominic J Smiraglia; Joseph Olechnowicz; Lakshmeswari Ravi; Lakshmi Kasturi; Lois Myeroff; Christoph Plass; Ramon Parsons; John D Minna; James Willson; Sylvan B Green; Jean-Pierre J Issa; Sanford D Markowitz
HLTF gene silencing in human colon cancer.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(7):4562-7.
2002: Sanford D Markowitz; Dawn M Dawson; Joseph Willis; James Willson
Focus on colon cancer.
Cancer cell 2002;1(3):233-6.
2002: Tian-Li Wang; Carlo Rago; Natalie Silliman; Janine Ptak; Sanford Markowitz; James Willson; Giovanni Parmigiani; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Prevalence of somatic alterations in the colorectal cancer cell genome.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(5):3076-80.
2002: Hui Li; Lois Myeroff; Lakshmi Kasturi; Lisa Krumroy; Stuart Schwartz; James Willson; Eric Stanbridge; Graham Casey; Sanford Markowitz
Chromosomal autonomy of hMLH1 methylation in colon cancer.
Oncogene 2002;21(9):1443-9.
2002: Petra Platzer; Madhvi B Upender; Keith Wilson; Joseph Willis; James Lutterbaugh; Arman Nosrati; James Willson; David Mack; Thomas Ried; Sanford Markowitz
Silence of chromosomal amplifications in colon cancer.
Cancer research 2002;62(4):1134-8.
2002: Srinivas Venkateswarlu; Dawn M Dawson; Patricia St Clair; Anjana Gupta; James Willson; Michael G Brattain
Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells.
Oncogene 2002;21(1):78-86.
2001: Afshin Dowlati; John R Haaga; Scot C Remick; Timothy P Spiro; Stanton L Gerson; Lili Liu; Sosamma J Berger; Nathan A Berger; James Willson
Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):2971-6.
2001: Lili Liu; Timothy P Spiro; Xiusheng Qin; Susan Majka; John R Haaga; Jane E Schupp; James Willson; Stanton L Gerson
Differential degradation rates of inactivated alkyltransferase in blood mononuclear cells and tumors of patients after treatment with O(6)-benzylguanine.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2318-24.
2001: Timothy P Spiro; Lili Liu; Susan Majka; John R Haaga; James Willson; Stanton L Gerson
Temozolomide: the effect of once- and twice-a-day dosing on tumor tissue levels of the DNA repair protein O(6)-alkylguanine-DNA-alkyltransferase.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2309-17.
2001: Claudia S Moy; Daniel M Albert; Marie Diener-West; LEONORA MCCAFFREY; R E Scully; James Willson
Cause-specific mortality coding. methods in the collaborative ocular melanoma study coms report no. 14.
Controlled clinical trials 2001;22(3):248-62.
2001: Lin Zhang; J Yu; James Willson; Sanford D Markowitz; Kenneth W Kinzler; Bert Vogelstein
Short mononucleotide repeat sequence variability in mismatch repair-deficient cancers.
Cancer research 2001;61(9):3801-5.
2001: S Thiagalingam; SJ Laken; James Willson; Sanford D Markowitz; Kenneth W Kinzler; Bert Vogelstein; Christoph Lengauer
Mechanisms underlying losses of heterozygosity in human colorectal cancers.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(5):2698-702.
2001: Stephen P Fink; Sandra Swinler; James Lutterbaugh; J Massagué; S Thiagalingam; Kenneth W Kinzler; Bert Vogelstein; James Willson; Sanford Markowitz
Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.
Cancer research 2001;61(1):256-60.
1999: S C Ye; Jason M Foster; Wenhui Li; Jing Liang; Elizabeth Zborowska; Srinivas Venkateswarlu; JianGen Gong; Michael G Brattain; James Willson
Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
Cancer research 1999;59(18):4725-31.
1999: Timothy P Spiro; Stanton L Gerson; Lili Liu; Susan Majka; John R Haaga; Charles L Hoppel; Stephen T Ingalls; J M Pluda; James Willson
O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.
Cancer research 1999;59(10):2402-10.
1999: Degeng Wang; Luzhe Sun; Elizabeth Zborowska; James Willson; JianGen Gong; J Verraraghavan; Michael G Brattain
Control of type II transforming growth factor-beta receptor expression by integrin ligation.
The Journal of biological chemistry 1999;274(18):12840-7.
1999: Cecilia M Whitacre; Elizabeth Zborowska; James Willson; Nathan A Berger
Detection of poly(ADP-ribose) polymerase cleavage in response to treatment with topoisomerase I inhibitors: a potential surrogate end point to assess treatment effectiveness.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(3):665-72.
1999: William M Grady; Lois Myeroff; Sandra Swinler; Ashwani Rajput; S Thiagalingam; James Lutterbaugh; A Neumann; Michael G Brattain; J Chang; S J Kim; Kenneth W Kinzler; Bert Vogelstein; James Willson; Sanford Markowitz
Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.
Cancer research 1999;59(2):320-4.
1998: D Jiang; Haisu Yang; James Willson; Jing Liang; Lisa E Humphrey; Elizabeth Zborowska; Degeng Wang; J Foster; R Fan; Michael G Brattain
Autocrine transforming growth factor alpha provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth states.
The Journal of biological chemistry 1998;273(47):31471-9.
1998: Kornelia Polyak; Y Li; H Zhu; Christoph Lengauer; James Willson; Sanford D Markowitz; Michael A Trush; Kenneth W Kinzler; Bert Vogelstein
Somatic mutations of the mitochondrial genome in human colorectal tumours.
Nature genetics 1998;20(3):291-3.
1998: James R Eshleman; G Casey; M E Kochera; W David Sedwick; Sandra Swinler; Martina L Veigl; James Willson; Stuart Schwartz; Sanford D Markowitz
Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53.
Oncogene 1998;17(6):719-25.
1998: Y Ko; SS Banerji; Ye Liu; Wenhui Li; Jing Liang; H D Soule; R J Pauley; James Willson; Elizabeth Zborowska; Michael G Brattain
Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
Journal of cellular physiology 1998;176(2):424-34.
1998: James G Herman; A Umar; Kornelia Polyak; Jeremy R Graff; NITA AHUJA; Jean-Pierre J Issa; Sanford Markowitz; James Willson; Stanley R Hamilton; Kenneth W Kinzler; Michael F Kane; Richard D Kolodner; Bert Vogelstein; T A Kunkel; Stephen B Baylin
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(12):6870-5.
1998: Gillian M Howell; Lisa E Humphrey; Rana A Awwad; Degeng Wang; Alan P Koterba; B Periyasamy; Jun Yang; Wenhui Li; James Willson; Barry Ziober; K Coleman; J Carboni; M Lynch; Michael G Brattain
Aberrant regulation of transforming growth factor-alpha during the establishment of growth arrest and quiescence of growth factor independent cells.
The Journal of biological chemistry 1998;273(15):9214-23.
1998: Daniel P Cahill; Christoph Lengauer; J Yu; Gregory J Riggins; James Willson; Sanford D Markowitz; Kenneth W Kinzler; Bert Vogelstein
Mutations of mitotic checkpoint genes in human cancers.
Nature 1998;392(6673):300-3.
1998: James R Eshleman; preston scott donover; Susan J Littman; Sandra Swinler; G M Li; James Lutterbaugh; James Willson; Paul Modrich; W David Sedwick; Sanford D Markowitz; Martina L Veigl
Increased transversions in a novel mutator colon cancer cell line.
Oncogene 1998;16(9):1125-30.
1998: Y Ko; KM Koli; SS Banerji; Wenhui Li; Elizabeth Zborowska; James Willson; Michael G Brattain; Carlos L Arteaga
A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells.
International journal of oncology 1998;12(1):87-94.
1998: Gillian M Howell; Lisa E Humphrey; Barry Ziober; Rana A Awwad; B Periyasamy; Alan P Koterba; Wenhui Li; James Willson; K Coleman; J Carboni; M Lynch; Michael G Brattain
Regulation of transforming growth factor alpha expression in a growth factor-independent cell line.
Molecular and cellular biology 1998;18(1):303-13.
1997: T L Stefan; Stephen T Ingalls; Paul E Minkler; James Willson; Stanton L Gerson; Timothy P Spiro; Charles L Hoppel
Simultaneous determination of O6-benzylguanine and 8-oxo-O6-benzylguanine in human plasma by reversed-phase high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications 1997;704(1-2):289-98.
1997: W P Phillips; James Willson; Sanford D Markowitz; Elizabeth Zborowska; N H Zaidi; Lili Liu; Nahida H Gordon; Stanton L Gerson
O6-methylguanine-DNA methyltransferase (MGMT) transfectants of a 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-sensitive colon cancer cell line selectively repopulate heterogenous MGMT+/MGMT- xenografts after BCNU and O6-benzylguanine plus BCNU.
Cancer research 1997;57(21):4817-23.
1997: JianGen Gong; Degeng Wang; Luzhe Sun; Elizabeth Zborowska; James Willson; Michael G Brattain
Role of alpha 5 beta 1 integrin in determining malignant properties of colon carcinoma cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1997;8(1):83-90.
1996: James Willson
Topoisomerase-I inhibitors in the management of colon cancer.
Annals of the New York Academy of Sciences 1996;803():256-63.
1996: Neal J Meropol; R Pazdur; mark vincent; James Willson; David P Kelsen; H O Douglass
Phase II study of ZD1694 in patients with advanced gastric cancer.
American journal of clinical oncology 1996;19(6):628-30.
1996: Michael G Brattain; Y Ko; SS Banerji; G Wu; James Willson
Defects of TGF-beta receptor signaling in mammary cell tumorigenesis.
Journal of mammary gland biology and neoplasia 1996;1(4):365-72.
1996: J Huang; Nickolas Papadopoulos; A J McKinley; Susan M Farrington; Lucy J Curtis; Andrew H Wyllie; S Zheng; James Willson; S D Markowitz; Patrice J Morin; Kenneth W Kinzler; Bert Vogelstein; Malcolm G Dunlop
APC mutations in colorectal tumors with mismatch repair deficiency.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(17):9049-54.
1996: D Liu; Eric Pearlman; Eugenia Diaconu; K Guo; H Mori; Tariq M Haqqi; Sanford Markowitz; James Willson; Man-Sun Sy
Expression of hyaluronidase by tumor cells induces angiogenesis in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(15):7832-7.
1996: Jianyong Wang; W Han; Elizabeth Zborowska; Jing Liang; X Wang; James Willson; Luzhe Sun; Michael G Brattain
Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells.
The Journal of biological chemistry 1996;271(29):17366-71.
1996: C Wang; James R Eshleman; James Lutterbaugh; Y Bin; James Willson; S Markowitz
Spontaneous apoptosis in human colon tumor cell lines and the relation of wt p53 to apoptosis.
Chinese medical journal 1996;109(7):537-41.
1996: S Thiagalingam; N A Lisitsyn; M Hamaguchi; Michael Wigler; James Willson; Sanford D Markowitz; F S Leach; Kenneth W Kinzler; Bert Vogelstein
Evaluation of the FHIT gene in colorectal cancers.
Cancer research 1996;56(13):2936-9.
1996: Gregory J Riggins; S Thiagalingam; E Rozenblum; C L Weinstein; Scott E Kern; Stanley R Hamilton; James Willson; Sanford D Markowitz; Kenneth W Kinzler; Bert Vogelstein
Mad-related genes in the human.
Nature genetics 1996;13(3):347-9.
1996: S Thiagalingam; Christoph Lengauer; F S Leach; Mieke Schutte; Stephan Hahn; J Overhauser; James Willson; Sanford Markowitz; Stanley R Hamilton; Scott E Kern; Kenneth W Kinzler; Bert Vogelstein
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers.
Nature genetics 1996;13(3):343-6.
1996: T L Stefan; Stephen T Ingalls; Stanton L Gerson; James Willson; Charles L Hoppel
Determination of O6-benzylguanine in human plasma by reversed-phase high-performance liquid chromatography.
Journal of chromatography. B, Biomedical applications 1996;681(2):331-8.
1996: Michael G Brattain; S D Markowitz; James Willson
The type II transforming growth factor-beta receptor as a tumor-suppressor gene.
Current opinion in oncology 1996;8(1):49-53.
1995: R Parsons; Lois Myeroff; B Liu; James Willson; Sanford D Markowitz; Kenneth W Kinzler; Bert Vogelstein
Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer.
Cancer research 1995;55(23):5548-50.
1995: C Y Wang; James R Eshleman; James Willson; S Markowitz
Both transforming growth factor-beta and substrate release are inducers of apoptosis in a human colon adenoma cell line.
Cancer research 1995;55(21):5101-5.
1995: Jianyong Wang; Luzhe Sun; Lois Myeroff; X Wang; L E Gentry; J Yang; Jing Liang; Elizabeth Zborowska; Sanford Markowitz; James Willson
Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells.
The Journal of biological chemistry 1995;270(37):22044-9.
1995: James Willson; John R Haaga; J E Trey; T A Stellato; Nahida H Gordon; Stanton L Gerson
Modulation of O6-alkylguanine alkyltransferase-directed DNA repair in metastatic colon cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(9):2301-8.
1995: Nickolas Papadopoulos; N C Nicolaides; B Liu; R Parsons; Christoph Lengauer; Fabio Palombo; A D'Arrigo; Sanford Markowitz; James Willson; Kenneth W Kinzler
Mutations of GTBP in genetically unstable cells.
Science (New York, N.Y.) 1995;268(5219):1915-7.
1995: Stanton L Gerson; James Willson
O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance.
Hematology/oncology clinics of North America 1995;9(2):431-50.
1995: Gillian M Howell; Barry Ziober; Lisa E Humphrey; James Willson; Luzhe Sun; M Lynch; Michael G Brattain
Regulation of autocrine gastrin expression by the TGF alpha autocrine loop.
Journal of cellular physiology 1995;162(2):256-65.
1995: James R Eshleman; E Z Lang; G K Bowerfind; R Parsons; Bert Vogelstein; James Willson; Martina L Veigl; W David Sedwick; Sanford D Markowitz
Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer.
Oncogene 1995;10(1):33-7.
1995: B Liu; N C Nicolaides; Sanford Markowitz; James Willson; R E Parsons; Jin Jen; N Papadopolous; Päivi Peltomäki; ALBERT DE LA CHAPELLE; Stanley R Hamilton
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability.
Nature genetics 1995;9(1):48-55.
1995: L T da Costa; B Liu; Wafik S El-Deiry; S R Hamilton; Kenneth W Kinzler; Bert Vogelstein; S Markowitz; James Willson; ALBERT DE LA CHAPELLE; K M Downey
Polymerase delta variants in RER colorectal tumours.
Nature genetics 1995;9(1):10-1.
1994: Jin Jen; J W Harper; S H Bigner; D D Bigner; Nickolas Papadopoulos; Sanford Markowitz; James Willson; Kenneth W Kinzler; Bert Vogelstein
Deletion of p16 and p15 genes in brain tumors.
Cancer research 1994;54(24):6353-8.
1994: Luzhe Sun; G Wu; James Willson; Elizabeth Zborowska; J Yang; I Rajkarunanayake; Jianyong Wang; L E Gentry; X F Wang; Michael G Brattain
Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells.
The Journal of biological chemistry 1994;269(42):26449-55.
1994: B Liu; R E Parsons; Stanley R Hamilton; Gloria M Petersen; Henry T Lynch; P Watson; Sanford Markowitz; James Willson; J Green; ALBERT DE LA CHAPELLE
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds.
Cancer research 1994;54(17):4590-4.
1994: Sosamma J Berger; D Gosky; Elizabeth Zborowska; James Willson; Nathan A Berger
Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
Cancer research 1994;54(15):4077-83.
1994: J A Pietenpol; Nickolas Papadopoulos; Sanford Markowitz; James Willson; Kenneth W Kinzler; Bert Vogelstein
Paradoxical inhibition of solid tumor cell growth by bcl2.
Cancer research 1994;54(14):3714-7.
1994: Sanford D Markowitz; Lois Myeroff; M J Cooper; J Traicoff; M Kochera; James Lutterbaugh; M Swiriduk; James Willson
A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene.
The Journal of clinical investigation 1994;93(3):1005-13.
1994: Michael G Brattain; Gillian M Howell; Luzhe Sun; James Willson
Growth factor balance and tumor progression.
Current opinion in oncology 1994;6(1):77-81.
1993: Thomas G Pretlow; G S Ogrinc; Saeid B Amini; C M Delmoro; K F Molkentin; James Willson; Theresa P Pretlow
A better defined medium for human prostate cancer cells.
In vitro cellular & developmental biology. Animal 1993;29A(7):528-30.
1993: F S Leach; S J Elledge; C J Sherr; James Willson; Sanford Markowitz; Kenneth W Kinzler; Bert Vogelstein
Amplification of cyclin genes in colorectal carcinomas.
Cancer research 1993;53(9):1986-9.
1993: K J Smith; K A Johnson; T M Bryan; David E Hill; Sanford Markowitz; James Willson; C Paraskeva; Gloria M Petersen; Stanley R Hamilton; Bert Vogelstein
The APC gene product in normal and tumor cells.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(7):2846-50.
1993: S P Wu; Luzhe Sun; James Willson; Lisa E Humphrey; R Kerbel; Michael G Brattain
Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1993;4(2):115-23.
1993: Stanton L Gerson; Elizabeth Zborowska; K Norton; Nahida H Gordon; James Willson
Synergistic efficacy of O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone.
Biochemical pharmacology 1993;45(2):483-91.
1993: Barry Ziober; James Willson; L E Hymphrey; K Childress-Fields; Michael G Brattain
Autocrine transforming growth factor-alpha is associated with progression of transformed properties in human colon cancer cells.
The Journal of biological chemistry 1993;268(1):691-8.
1992: Nahida H Gordon; James Willson
Using toxicity grades in the design and analysis of cancer phase I clinical trials.
Statistics in medicine 1992;11(16):2063-75.
1992: D M Albert; A S Niffenegger; James Willson
Treatment of metastatic uveal melanoma: review and recommendations.
Survey of ophthalmology 1992;36(6):429-38.
1992: Stanton L Gerson; Nathan A Berger; C Arce; S J Petzold; James Willson
Modulation of nitrosourea resistance in human colon cancer by O6-methylguanine.
Biochemical pharmacology 1992;43(5):1101-7.
1992: S P Wu; Dan Theodorescu; R S Kerbel; James Willson; Kathleen M Mulder; Lisa E Humphrey; Michael G Brattain
TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector.
The Journal of cell biology 1992;116(1):187-96.
1991: D L Trump; Merrill J Egorin; A Forrest; James Willson; S Remick; K D Tutsch
Pharmacokinetic and pharmacodynamic analysis of fluorouracil during 72-hour continuous infusion with and without dipyridamole.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(11):2027-35.
1991: M Haut; P S Steeg; James Willson; Sanford D Markowitz
Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential.
Journal of the National Cancer Institute 1991;83(10):712-6.
1990: S J Baker; A C Preisinger; J M Jessup; C Paraskeva; Sanford Markowitz; James Willson; S Hamilton; Bert Vogelstein
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.
Cancer research 1990;50(23):7717-22.
1990: S J Baker; Sanford Markowitz; Eric R Fearon; James Willson; Bert Vogelstein
Suppression of human colorectal carcinoma cell growth by wild-type p53.
Science (New York, N.Y.) 1990;249(4971):912-5.
1990: Joan H Schiller; M A Horisberger; G Bittner; J M Carlin; B Storer; Gerald Byrne; James Willson; Ernest C Borden
Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle.
Journal of biological response modifiers 1990;9(4):368-77.
1990: Sanford D Markowitz; K Molkentin; C Gerbic; J Jackson; T Stellato; James Willson
Growth stimulation by coexpression of transforming growth factor-alpha and epidermal growth factor-receptor in normal and adenomatous human colon epithelium.
The Journal of clinical investigation 1990;86(1):356-62.
1990: S C Remick; J L Grem; P H Fischer; Kendra Tutsch; Dona Alberti; L M Nieting; Mary Beth Tombes; J Bruggink; James Willson; D L Trump
Phase I trial of 5-fluorouracil and dipyridamole administered by seventy-two-hour concurrent continuous infusion.
Cancer research 1990;50(9):2667-72.
1990: S Chakrabarty; S Mustain; James Willson
Induction of carcinoembryonic antigen and its crossreactive gene products in human colonic adenomas and carcinomas by transforming growth factor-beta.
Molecular biotherapy 1990;2(1):27-31.
1989: S C Remick; Al B Benson; J L Weese; James Willson; G Ramirez; G W Wirtanen; Dona Alberti; L M Nieting; Kendra Tutsch; P H Fischer
Phase I trial of hepatic artery infusion of 5-iodo-2'-deoxyuridine and 5-fluorouracil in patients with advanced hepatic malignancy: biochemically based combination chemotherapy.
Cancer research 1989;49(22):6437-42.
1989: Neil W Toribara; T L Sack; James R Gum; Samuel B Ho; J E Shively; James Willson; Young S Kim
Heterogeneity in the induction and expression of carcinoembryonic antigen-related antigens in human colon cancer cell lines.
Cancer research 1989;49(12):3321-7.
1989: James Willson; P H Fischer; S C Remick; Kendra Tutsch; J L Grem; L Nieting; Dona Alberti; J Bruggink; D L Trump
Methotrexate and dipyridamole combination chemotherapy based upon inhibition of nucleoside salvage in humans.
Cancer research 1989;49(7):1866-70.
1989: James Willson
Biology of large bowel cancer.
Hematology/oncology clinics of North America 1989;3(1):19-34.
1988: P H Fischer; James Willson; C Risueno; Kendra Tutsch; J Bruggink; A Ranhosky; D L Trump
Biochemical assessment of the effects of acivicin and dipyridamole given as a continuous 72-hour intravenous infusion.
Cancer research 1988;48(19):5591-6.
1988: James Willson; P H Fischer; Kendra Tutsch; Dona Alberti; K Simon; R D Hamilton; J Bruggink; J M Koeller; D C Tormey; R H Earhart
Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage.
Cancer research 1988;48(19):5585-90.
1988: Joan H Schiller; B Storer; G Bittner; James Willson; Ernest C Borden
Phase II trial of a combination of interferon-beta ser and interferon-gamma in patients with advanced malignant melanoma.
Journal of interferon research 1988;8(5):581-9.
1988: K A Havlin; Anna D Inglot; James Willson; Ernest C Borden; S Grossberg; B Szulc; Andrzej Gladysz; B Groehlich
Lack of interferon production by dipyridamole.
Journal of interferon research 1988;8(2):135-6.
1988: James Willson; G N Bittner
In vitro models of human colonic adenomatous polyps.
Progress in clinical and biological research 1988;279():347-56.
1987: J L Grem; Kendra Tutsch; K J Simon; D B Alberti; James Willson; D C Tormey; S Swaminathan; D L Trump
Phase I study of taxol administered as a short i.v. infusion daily for 5 days.
Cancer treatment reports 1987;71(12):1179-84.
1987: Joan H Schiller; B Storer; James Willson; Ernest C Borden
Phase I trial of combinations of recombinant interferons beta(ser) and gamma in patients with advanced malignancy.
Cancer treatment reports 1987;71(10):945-52.
1987: D L Trump; J L Grem; Kendra Tutsch; James Willson; K J Simon; D Alberti; B Storer; D C Tormey
Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretion.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(8):1281-9.
1987: D L Trump; K D Tutsch; James Willson; S Remick; K Simon; Dona Alberti; J Grem; J Koeller; D C Tormey
Phase I clinical trial and pharmacokinetic evaluation of acodazole (NSC 305884), an imidazoquinoline derivative with electrophysiological effects on the heart.
Cancer research 1987;47(14):3895-900.
1987: Joan H Schiller; G Bittner; B Storer; James Willson
Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines.
Cancer research 1987;47(11):2809-13.
1987: S C Remick; A J Neville; James Willson
Phase II trial evaluating continuous infusion of etoposide, cisplatin, and hexamethylmelamine in extensive-disease small cell carcinoma of the lung.
Cancer treatment reports 1987;71(6):575-80.
1987: James Willson; G N Bittner; T D Oberley; L F Meisner; J L Weese
Cell culture of human colon adenomas and carcinomas.
Cancer research 1987;47(10):2704-13.
1987: T J Van Mouwerik; C A Pangallo; James Willson; P H Fischer
Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole.
Biochemical pharmacology 1987;36(6):809-14.
1986: Joan H Schiller; James Willson; G Bittner; W H Wolberg; M J Hawkins; Ernest C Borden
Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay.
Journal of interferon research 1986;6(6):615-25.
1986: James Willson; M W Knuiman; R T Skeel; J M Wolter; K J Pandya; G Falkson; Y C Chang
Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
Cancer treatment reports 1986;70(10):1237-8.
1986: S Chakrabarty; Y J Danels; B H Long; James Willson; Michael G Brattain
Circumvention of deficient activation in mitomycin C-resistant human colonic carcinoma cells by the mitomycin C analogue BMY25282.
Cancer research 1986;46(7):3456-8.
1986: J H Schiller; D S Groveman; S M Schmid; James Willson; K B Cummings; Ernest C Borden
Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.
Cancer research 1986;46(2):483-8.
1986: M G Brattain; James Willson; B H Long; S Chakrabarty; Lynn Yeoman; D A Stringfellow
Overcoming mitomycin C resistance with semisynthetic derivatives.
Progress in clinical and biological research 1986;223():63-79.
1985: James Willson; B H Long; S Chakrabarty; D E Brattain; Michael G Brattain
Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cells.
Cancer research 1985;45(11 Pt 1):5281-6.
1984: J A McBain; J L Weese; L F Meisner; W H Wolberg; James Willson
Establishment and characterization of human colorectal cancer cell lines.
Cancer research 1984;44(12 Pt 1):5813-21.
1984: James Willson; B H Long; M E Marks; D E Brattain; J E Wiley; Michael G Brattain
Mitomycin C resistance in a human colon carcinoma cell line associated with cell surface protein alterations.
Cancer research 1984;44(12 Pt 1):5880-5.
1984: B H Long; James Willson; D E Brattain; S Musial; M G Brattain
Effects of mitomycin on human colon carcinoma cells.
Journal of the National Cancer Institute 1984;73(4):787-92.
1984: P H Fischer; R Pamukcu; G Bittner; James Willson
Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole.
Cancer research 1984;44(8):3355-9.
1984: James Willson; G Bittner; Ernest C Borden
Antiproliferative activity of human interferons against ovarian cancer cells grown in human tumor stem cell assay.
Journal of interferon research 1984;4(4):441-7.
1984: Michael G Brattain; A E Levine; S Chakrabarty; Lynn Yeoman; James Willson; B Long
Heterogeneity of human colon carcinoma.
Cancer metastasis reviews 1984;3(3):177-91.
1981: James Willson; R F Ozols; B J Lewis; R C Young
Current status of therapeutic modalities for treatment of gynecologic malignancies with emphasis on chemotherapy.
American journal of obstetrics and gynecology 1981;141(1):81-98.
1980: R F Ozols; James Willson; M D Weltz; K R Grotzinger; C E Myers; R C Young
Inhibition of human ovarian cancer colony formation by adriamycin and its major metabolites.
Cancer research 1980;40(11):4109-12.
1980: R F Ozols; James Willson; K R Grotzinger; R C Young
Cloning of human ovarian cancer cells in soft agar from malignant and peritoneal washings.
Cancer research 1980;40(8 Pt 1):2743-7.
1980: R F Ozols; James Willson; R C Young
Human ovarian cancer colony formation: growth from malignant washings and pharmacologic applications.
Progress in clinical and biological research 1980;48():247-57.
1978: James Willson
Pulmonary toxicity of antineoplastic drugs.
Cancer treatment reports 1978;62(12):2003-8.
1978: T G Pretlow; J I Kreisberg; G A Zieman; James Willson; A Pitts; J L Zaremba
Subpopulation of human tonsillar lymphocytes with mitochondria visible by light microscopy.
Blood 1978;52(4):762-9.
1977: James Willson; J Zaremba; T G Pretlow
Functional characterization of cells separated from suspensions of Hodgkin diseases tumor cells in an isokinetic gradient.
Blood 1977;50(5):783-97.
1976: James Willson; J L Zaremba; A M Pitts; T G Pretlow
A characterization of human tonsillar lymphocytes after separation from other tonsillar cells in an isokinetic gradient of ficoll in tissue culture medium.
The American journal of pathology 1976;83(2):341-58.
1976: James Willson; T G Pretlow; J L Zaremba; M G Brattain
Heterogeneity among preparations of crude trypsin used to disaggregate the human tonsil.
Immunology 1976;30(1):157-60.
1975: James Willson; D E Luberoff; A Pitts; T C Pretlow
A method for the separation of lymphocytes and plasma cells from the human palatine tonsil using sedimentation in an isokinetic gradient of Ficoll in tissue culture medium.
Immunology 1975;28(1):161-70.
1971: James Willson; M Eskridge; E L Scott
Transbronchial biopsy of benign and malignant peripheral lung lesions. Description of three new instruments.
Radiology 1971;100(3):541-6.
1959: James Willson
The bone lesions of childhood leukemia; a survey of 140 cases.
Radiology 1959;72(5):672-81.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.